episiotomy wound. Disruption of perineal obstetric wound
Conditions
Interventions
Intervention 1: control group: non-intervention. Intervention 2: control group: consuming placebo ointment. Placebo ointment was Vaseline without extract in 30gr tubes. The patients were selected amon
this was continued twice a day for ten days. Intervention 3: case group: consuming Achillea millefolium ointment. Achillea millefolium purchased from medical plants sellers and after proving the ident
this was continued twice a day for ten days. Intervention 4: case group: consuming Hypericum perforatum ointment. Hypericum perforatum purchased from medical plants sellers and after proving the ident
Placebo
Treatment - Drugs
control group: non-intervention
control group: consuming placebo ointment. Placebo ointment was Vaseline without extract in 30gr tubes. The patients were selected among women who refferd to shahrekord health centers for routine pren
this was continued twice a day for ten days.
case group: consuming Achillea millefolium ointment. Achillea millefolium purchased from medical plants sellers and after proving the identity by Medical Plants Research Center of Shahrekord Universit
this was continued twice a day for t
case group: consuming Hypericum perforatum ointment. Hypericum perforatum purchased from medical plants sellers and after proving the identity by Medical Plants Research Center of Shahrekord Universit
Sponsors
Shahrekord University of Medical Sceinces
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: • Being nulliparous • Gestational age of 37-42 weeks • Having a single fetus • Not to use particular medications (such as glucocorticoids, anticoagulant, chemotherapy, immunosuppressant and radiotherapy) • No history of the diseases that disrupt wound healing process such as chronic systemic diseases, cardiac, renal, pulmonary diseases, coagulation disorders, immune deficiency, connective tissue disorder and diabetes • Not having anemia, mental illnesses, persistent constipation, hemorrhoid, hemophilia and malnutrition • no allergic history of herbal medicines • Body mass index of 19/8-26 • having no active skin diseases such as allergic disorders, skin irritation or wound in Incision site and symptomatic vaginitis • Not using antibiotics after episiotomy • no history of perineal repair surgery • no history of genital warts Exclusion critera: • Cephalopelvic disproportion in pelvic exam • Disruption in labor progress (first delivery stage > 20hours, and prolonged second delivery stage > 2hours (prolonged labor) or cervical dilation progress = 5cm in hour or labor duration 18hours) • abnormal postpartum hemorrhage or hematoma • irregular use of ointment (< 7days or 14 times) • onset complications such as itching or skin irritation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: Patient explained perineal pain level by a number of 0-10 at second, 7th & 10th & 14th days postpartum. Method of measurement: visual analogue scale.;The healing process by 5 specifications: redness, ecchymosis, edema, discharge and wound dehiscence. Timepoint: at 7th, 10th and 14th days after delivery. Method of measurement: researcher assessed redness, edema and ecchymosis in millimeters and charted in perineal repair control form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Keivani
Shahrekord University of Medical Sciences
Outcome results
None listed